News
One small city's bid to rescue its health finances has transformed the way health care is managed across China. Chris McCall ...
Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...
The health secretary said the New England Journal of Medicine, the Journal of the American Medical Association and The Lancet ...
Health Secretary Robert F. Kennedy Jr. took aim at reputed journals such as the Lancet and said his agency will create ...
A new study published in The Lancet journal showed that Gepotidacin was non-inferior to the standard treatment of ceftriaxone ...
Safiyyah Abbas and Lucy Mitchell1 highlighted the atrocities unfolding in Gaza and the failure of Australian medical institutions to mount a meaningful protest. Since then, the Israeli Government's ...
Amycretin is a unimolecular long-acting GLP-1 and amylin receptor agonist under development by Novo Nordisk, to provide an ...
Tom McAndrew, a computational scientist and associate professor in Lehigh's College of Health, recently published a paper in ...
2dOpinion
The New Republic on MSNNote to Democrats: War With Iran Is a Monumental MistakeThe hard lessons the party has learned since Iraq point to one conclusion: Launching a new Middle East war would be a ...
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results